ロード中...
Management of diabetes mellitus in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon
Canagliflozin is the first available oral inhibitor of sodium/glucose cotransporter 2 (SGLT2) in the market. At the outset it sounds excellent for the use in the elderly diabetic population, because of its minimal tendency to cause hypoglycemia. However, the clinician needs to exercise caution as it...
保存先:
| 出版年: | J Pharmacol Pharmacother |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4231550/ https://ncbi.nlm.nih.gov/pubmed/25422561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.142428 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|